Jade Biosciences Inc.
JBIO | NASDAQ
$13.78
-$0.28 (-1.99%)
Nov 2, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -153.24M | -129.61M | -127.41M | -125.59M | -117.28M | -109.92M | -94.94M | -85.24M | -87.94M | -63.16M | -39.98M | -19.56M |
Depreciation & Amortization | 39K | 35K | 26K | 17K | 5K | 28K | 56K | 84K | 109K | 81K | 53K | 25K |
Stock-Based Compensation | 21.1M | 24.99M | 20.01M | 11.84M | 7.57M | 3.68M | 1.26M | 27K | n/a | n/a | n/a | n/a |
Other Working Capital | -3.29M | -450K | -8.56M | 3.46M | 7.69M | 8.32M | 4.62M | 7.76M | 3.23M | 3.04M | 7.83M | 3.51M |
Other Non-Cash Items | 12.03M | 5.01M | 20.88M | 32.37M | 34.26M | 31.18M | 19.21M | 10.63M | 11.36M | 8.18M | 4.74M | 2.43M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.44M | -438K | -8.2M | 4.51M | 13.92M | 13.23M | 7.69M | 8.8M | 1.96M | 815K | 4.77M | 1.5M |
Operating Cash Flow | -123.51M | -100.01M | -94.69M | -76.85M | -61.53M | -61.8M | -66.72M | -65.71M | -74.52M | -54.08M | -30.41M | -15.61M |
Capital Expenditures | -60K | -60K | -60K | -57K | n/a | n/a | n/a | -64K | -96K | -96K | -96K | -32K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -328.82M | -186.5M | -112.6M | n/a | n/a | n/a | -14.75M | -42.54M | -90.39M | -90.39M | -75.64M | -47.85M |
Sales Maturities Of Investments | 110.12M | 65.43M | n/a | n/a | n/a | 18M | 41.58M | 75.08M | 109.83M | 91.83M | 68.25M | 34.75M |
Other Investing Acitivies | -134.21M | -134.34M | -134.34M | -148.79M | -136K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -352.97M | -255.48M | -247.01M | -148.84M | -136K | 18M | 26.83M | 32.48M | 19.35M | 1.35M | -7.48M | -13.13M |
Debt Repayment | n/a | n/a | n/a | n/a | 95M | 95M | 95M | 95M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 362.65M | 361.97M | 362.11M | 187.84M | 187.61M | -3.7M | -3M | -228K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 362.89M | 360.67M | 360.77M | 187.84M | 282.61M | 115.68M | 116.85M | 120.09M | 25.33M | 954K | 483K | 20K |
Net Cash Flow | -113.69M | 5.16M | 19.05M | -37.86M | 220.94M | 71.88M | 76.96M | 86.86M | -29.83M | -51.78M | -37.41M | -28.72M |
Free Cash Flow | -123.57M | -100.07M | -94.75M | -76.91M | -61.53M | -61.8M | -66.72M | -65.77M | -74.61M | -54.18M | -30.51M | -15.64M |
Adj. Free Cash Flow | -144.67M | -125.06M | -114.76M | -88.75M | -69.1M | -65.48M | -67.98M | -65.8M | -74.61M | -54.18M | -30.51M | -15.64M |
Maintenance CapEx | -15K | -15K | -15K | -12K | n/a | n/a | n/a | -28K | -53K | n/a | n/a | n/a |
Growth CapEx | -45K | -45K | -45K | -45K | n/a | n/a | n/a | -36K | -43K | n/a | n/a | n/a |
Owner Earnings | -123.53M | -100.03M | -94.7M | -76.86M | -61.53M | -61.8M | -66.72M | -65.74M | -74.57M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove JBIO